Spruce Biosciences, Inc. (SPRB)
60.78
-2.52
(-3.98%)
USD |
NASDAQ |
Aug 28, 16:00
60.60
-0.18
(-0.30%)
After-Hours: 20:00
Spruce Biosciences Free Cash Flow : -42.77M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -42.77M |
| March 31, 2026 | -29.34M |
| December 31, 2025 | -33.33M |
| September 30, 2025 | -47.55M |
| June 30, 2025 | -51.46M |
| March 31, 2025 | -53.73M |
| December 31, 2024 | -55.96M |
| September 30, 2024 | -46.50M |
| June 30, 2024 | -49.55M |
| March 31, 2024 | -36.45M |
| December 31, 2023 | -33.28M |
| September 30, 2023 | -33.81M |
| Date | Value |
|---|---|
| June 30, 2023 | -30.12M |
| March 31, 2023 | -41.66M |
| December 31, 2022 | -41.69M |
| September 30, 2022 | -39.76M |
| June 30, 2022 | -38.84M |
| March 31, 2022 | -38.99M |
| December 31, 2021 | -35.97M |
| September 30, 2021 | -35.46M |
| June 30, 2021 | -35.33M |
| March 31, 2021 | -30.44M |
| December 31, 2020 | -27.59M |
| September 30, 2020 | -21.21M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biogen, Inc. | 2.49B |
| PTC Therapeutics, Inc. | -332.49M |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
| Alnylam Pharmaceuticals, Inc. | 793.94M |
| Anika Therapeutics, Inc. | 0.562M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -22.12M |
| Cash from Investing (Quarterly) | -0.135M |
| Cash from Financing (Quarterly) | 64.47M |
| Free Cash Flow Per Share (Quarterly) | -9.154 |
| Free Cash Flow to Equity (Quarterly) | -22.80M |
| Free Cash Flow to Firm (Quarterly) | -21.16M |
| Free Cash Flow Yield | -49.05% |